Remeglurant
Remeglurant ( ; developmental code name MRZ-8456) is a drug which acts as a selective antagonist of the mGlu 5 receptor.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Remeglurant ( ; developmental code name MRZ-8456) is a drug which acts as a selective antagonist of the mGlu 5 receptor. It is under development by Merz Pharmaceuticals for the treatment of drug-induced dyskinesia but no development has been reported since at least 2016.
See also
Basimglurant Dipraglurant Fenobam Mavoglurant Raseglurant
Text derived from https://en.wikipedia.org/w/index.php?oldid=1329042015 under CC BY-SA 4.0; modifications have been made.